e-learning
resources
Virtual 2021
06.09.2021
Management of chronic cough and obstructive diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Modelling Rhinovirus-16 (RV16) Infection using Human Precision Cut Lung Slices (PCLS)
R. Stinson (Hull , United Kingdom), A. Morice (Hull , United Kingdom), L. Sadofsky (Hull, United Kingdom)
Source:
Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Session:
Management of chronic cough and obstructive diseases
Session type:
E-poster
Number:
1944
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Stinson (Hull , United Kingdom), A. Morice (Hull , United Kingdom), L. Sadofsky (Hull, United Kingdom). Modelling Rhinovirus-16 (RV16) Infection using Human Precision Cut Lung Slices (PCLS). 1944
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Precision Cut Lung Slices (PCLS) Thickness has Limited Impact on Tissue Viability
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Development of Highly Organized Human Leukocyte Infiltration Patterns and Human Lymphoid Tissue in Lungs of Humanized Immune System (HIS) Mice
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019
Krüppel-like Factor 4 (Klf4) in human and mouse lung development: Regulation of ATII Cell Homeostasis in Lungs of Newborn Mice Exposed to HYX
Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Year: 2018
Use of Airway Epithelial Cell Cultures in Inflammatory Lung Disease Research
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009
Lung Clearance Index (LCI)
Source: Research Seminar 2012 - Preparing for the first early pulmonary intervention studies in infants and preschool childrenwith Cystic Fibrosis
Year: 2012
Identification of Cell Populations with Increase Expression of Markers of Cell Senescence in Explanted IPF Lungs
Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Mechanical Preconditioning of Lung Mesenchymal Stem Cells Improves Ventilation Induced Lung Injury in Rats
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018
Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
LSC - 2017 - Proteasomal Activator 200 (PA200) Regulates Cellular Proliferation: A Putative Role For IPF And Lung Cancer Pathogenesis
Source: International Congress 2017 – New insights into pathogenesis of lung disease
Year: 2017
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019
Source: ERJ Open Res, 6 (4) 00123-2020; 10.1183/23120541.00123-2020
Year: 2020
LSC - 2017 - Reprogramming Of Tumor Associated Macrophages By Modulating Wnt/ß-catenin Signalling In Lung Cancer.
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017
Effects of Sustained and Intermittent Hypoxia on Human Lung Cancer Cells
Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing
Year: 2019
DiscovAIR: Basic science - Human Lung Cell Atlas
Source: Virtual Congress 2020 – Genom revolution: Human Lung Cell Atlas
Year: 2020
Aerobic Exercise Effects in Severe Asthma: Involvement of Lung Fibroblast (MRC-5) Cells and Kinins Signaling
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Single Cell RNA-seq Reveals Zinc Metabolism Defect of Alveolar Type II Cells with Aging in IPF
Source: ERS Lung Science Conference 2020
Year: 2020
Quantitative Assessment of Regional Compliance and Resistance in a Mouse Model of Emphysema with micro-Computed Tomography (micro-CT)
Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease
Year: 2020
The Human Lung Cell Atlas: a transformational resource for cells of the respiratory system
Source: Eur Respir Monogr 2021; 91: 158-174
Year: 2021
LATE-BREAKING ABSTRACT: The use of in vitro Human Airway Epithelia for the development of novel antivirals against human rhinoviruses (HRV)
Source: International Congress 2014 – Respiratory infections in children
Year: 2014
Exosomes from Intermittent Hypoxia Treated Lung Adenocarcinoma Cell Line Up-regulate Programmed Death Ligand 1 Expression through HIF-1a Pathway in Macrophages
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020
Rhinovirus Challenge in Asthmatics and Healthy Volunteers to Evaluate the Safety and Appropriate Dose of a GMP Human Rhinovirus 16 Preparation for Challenge Studies in Mild-Moderate Asthmatics taking ICS
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept